Insider Transactions in Q4 2022 at Brookline Capital Acquisition Corp. (BCAC)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2022
|
Frank J. Hsu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,323
-17.29%
|
$4,323
$1.06 P/Share
|
|
Dec 15
2022
|
Francis Willard Sarena President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,916
-17.29%
|
$6,916
$1.06 P/Share
|
|
Dec 15
2022
|
Amy Wong SVP, Finance and Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
2,851
-17.29%
|
$2,851
$1.06 P/Share
|
|
Dec 15
2022
|
Xiaodong Yang Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,001
-1.3%
|
$7,001
$1.06 P/Share
|
|
Dec 15
2022
|
William E. Duke Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,503
-14.67%
|
$4,503
$1.06 P/Share
|
|
Oct 07
2022
|
Amy Wong SVP, Finance and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
16,488
+50.0%
|
-
|
|
Oct 07
2022
|
Francis Willard Sarena President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+50.0%
|
-
|
|
Oct 07
2022
|
Frank J. Hsu Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+50.0%
|
-
|
|
Oct 07
2022
|
William E. Duke Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,685
+50.0%
|
-
|
|
Oct 07
2022
|
Xiaodong Yang Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,488
+6.99%
|
-
|